Dane Saglio

Dane Saglio

Directeur Financier/CFO chez BULLFROG AI HOLDINGS, INC.

Fortune : 163 426 $ au 30/04/2024

66 ans
Health Technology
Finance
Technology Services

Provenance du réseau au premier degré de Dane Saglio

EntitéType d'entitéIndustrie
16
Extinct Pharmaceuticals: Major 16
Unknown 10
5
Extinct Chemicals: Specialty 5
5
Subsidiary Medical/Nursing Services 5
Extinct Biotechnology 4
Public Company Pharmaceuticals: Major 2
1
Subsidiary Packaged Software 1

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Dane Saglio via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Finance/Rental/Leasing

Cary Claiborne

Corporate Officer/Principal

LADRX CORPORATION Biotechnology

Cary Claiborne

Director/Board Member

MEDICIS PHARMACEUTICAL CORP Pharmaceuticals: Major

John W. Holaday

Jason Hanson

Peter Knight

Founder

Chief Operating Officer

Director/Board Member

OSIRIS THERAPEUTICS, INC. Biotechnology

Jim Burns

Cary Claiborne

Chief Executive Officer

Director of Finance/CFO

GENVEC INC Pharmaceuticals: Major

William Enright

Margot Mongold

Corporate Officer/Principal

Human Resources Officer

AVANIR PHARMACEUTICALS INC Pharmaceuticals: Major

David Mazzo

Director/Board Member

MAXCYTE, INC. Biotechnology

John W. Holaday

Vininder Singh

Founder

Founder

Pharmaceuticals: Major

Kenneth Carter

Director/Board Member

ADIAL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Cary Claiborne

Chief Executive Officer

NEXIMMUNE, INC. Pharmaceuticals: Major

Kenneth Carter

Chief Executive Officer

Pharmaceuticals: Major

Kenneth Carter

Founder

INDIVIOR PLC Pharmaceuticals: Major

Cary Claiborne

Director of Finance/CFO

Michigan State University College/University

R. Elsey

Billl Hirschman

Masters Business Admin

Undergraduate Degree

University of Pittsburgh College/University

Gerald J. Vardzel

Kristin Bigos

Undergraduate Degree

Doctorate Degree

George Washington University College/University

L. Thompson Bowles

Margot Mongold

Corporate Officer/Principal

Graduate Degree

Pharmaceuticals: Other

David Mazzo

Corporate Officer/Principal

Real Estate Development

David Mazzo

Corporate Officer/Principal

American University College/University

Marc G. Corrado

Margot Mongold

Graduate Degree

Undergraduate Degree

Rutgers State University of New Jersey College/University

Jennie C. Hunter-Cevera

Cynthia Hu

Cary Claiborne

Vininder Singh

Doctorate Degree

Graduate Degree

Undergraduate Degree

Undergraduate Degree

The Johns Hopkins University College/University

John W. Holaday

Vininder Singh

Corporate Officer/Principal

Masters Business Admin

College/University

Dwight Bush

Jason Hanson

Peter Knight

Director/Board Member

Undergraduate Degree

Undergraduate Degree

New York University College/University

Cynthia Hu

L. Thompson Bowles

Undergraduate Degree

Doctorate Degree

University of Illinois College/University

Jim Burns

Thomas Hazel

Graduate Degree

Doctorate Degree

Villanova University College/University

Cary Claiborne

David Mazzo

Masters Business Admin

Undergraduate Degree

SUCAMPO PHARMACEUTICALS, INC. Pharmaceuticals: Major

Cary Claiborne

Director of Finance/CFO

Biotechnology

David Mazzo

Corporate Officer/Principal

University of Texas Medical Branch College/University

Kenneth Carter

Doctorate Degree

Miscellaneous Commercial Services

Cary Claiborne

Director/Board Member

Medical Specialties

David Mazzo

Corporate Officer/Principal

AOAC International

David Mazzo

Corporate Officer/Principal

Maryland Health Care Product Development Corp.

Kenneth Carter

Director/Board Member

Bonnie Brae, Inc.

David Mazzo

Director/Board Member

Miscellaneous Commercial Services

Cary Claiborne

Director of Finance/CFO

PREDICTIVE ONCOLOGY INC. Medical Specialties

Sean McDonald

Gerald J. Vardzel

Chief Executive Officer

Director/Board Member

UMass Chan Medical School College/University

Kenneth Carter

Graduate Degree

Financial Conglomerates

Kenneth Carter

Director/Board Member

Investment Managers

Kenneth Carter

Founder

Biotechnology

Kenneth Carter

Director/Board Member

Biotechnology

Matthew Kalnik

Kenneth Carter

Chief Executive Officer

Director/Board Member

NEUROSENSE THERAPEUTICS LTD. Pharmaceuticals: Major

Cary Claiborne

Director/Board Member

Biotechnology

Kenneth Carter

Director/Board Member

Prosperity Capital Management LLC

Cary Claiborne

Chief Executive Officer

APOLLOMICS, INC. Pharmaceuticals: Major

Kenneth Carter

Director/Board Member

Statistiques

Internationale

Etats-Unis 44
Canada 2
Royaume-Uni 2
Suisse 2
France 2

Sectorielle

Health Technology 27
Consumer Services 13
Finance 5
Commercial Services 3
Industrial Services 2

Opérationnelle

Director/Board Member 162
Corporate Officer/Principal 90
President 56
Chief Executive Officer 49
Founder 46
  1. Bourse
  2. Insiders
  3. Dane Saglio
  4. Connexions Sociétés